Resultados de la búsqueda 311-320 of 10460 for breast cancer men

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... breast cancer stay on their hormone therapy medicines. Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors.

  3. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. tlc2167 · Grade 1 invasive ductal carcinoma in a male. 12 Replies Wed, Jun 19, 2024.

  4. Salud de la mujer Noticias de la Mayo Clinic - Mayo Clinic

    Heart attack symptoms in women are often different than men Feb. ... Toolkit for reducing cervical cancer ... Exploring advanced breast cancer screening options Oct ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease. Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... breast cancer among patients who are diagnosed with DCIS. Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal ...

  9. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. tlc2167 · Grade 1 invasive ductal carcinoma in a male. 14 Replies Thu, Jun 20, 2024.

  10. Oncología (médica) - Ensayos clínicos

    Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer. Rochester, Minn. The purpose of this study is to evaluate a new treatment using a ...